Cannabis research continues to evolve rapidly, with new clinical applications emerging while regulatory frameworks struggle to keep pace. Healthcare professionals need current, evidence-based information to guide patient discussions and treatment decisions in this complex therapeutic landscape.

The current state of cannabis research reveals a patchwork of promising therapeutic applications alongside significant knowledge gaps. Clinical evidence supports cannabis efficacy for specific conditions including treatment-resistant epilepsy, chemotherapy-induced nausea, and chronic pain syndromes, with varying degrees of confidence across indications. The endocannabinoid system’s broad physiological influence suggests potential for diverse therapeutic applications, yet most research remains preliminary or limited by study design constraints. Dosing protocols lack standardization across products and delivery methods, complicating clinical implementation. Patient safety considerations include drug interactions, particularly with sedating medications and anticoagulants, alongside concerns about psychiatric comorbidities and substance use history.

“I approach cannabis as I would any therapeutic intervention—with careful consideration of individual patient factors, clear treatment goals, and systematic monitoring. The key is matching specific cannabinoid profiles and delivery methods to each patient’s clinical presentation and treatment history.”

💬 Join the Conversation

Have a question about how this applies to your situation? Ask Dr. Caplan →

Want to discuss this topic with other patients and caregivers? Join the forum discussion →

Have thoughts on this? Share it: